{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:17:28Z","timestamp":1794579448805,"version":"4.9.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s13365-023-01114-6","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T16:02:31Z","timestamp":1676563351000},"page":"111-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5935-5063","authenticated-orcid":false,"given":"Beyza","family":"Cifci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-4112","authenticated-orcid":false,"given":"Yesim","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6020-6022","authenticated-orcid":false,"given":"Emine","family":"Altin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3981-2850","authenticated-orcid":false,"given":"Hamid","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2580-9650","authenticated-orcid":false,"given":"Belgin","family":"Kocer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-0781","authenticated-orcid":false,"given":"Murat","family":"Dizbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"issue":"1","key":"1114_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/brain\/81.1.93","volume":"81","author":"KE Astrom","year":"1958","unstructured":"Astrom KE, Mancall EL, Richardson EP Jr (1958) Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin\u2019s disease. Brain 81(1):93\u2013111. https:\/\/doi.org\/10.1093\/brain\/81.1.93","journal-title":"Brain"},{"key":"1114_CR2","doi-asserted-by":"publisher","unstructured":"Bauer J, Gold R, Adams O, Lassmann H (2015) Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS). Acta Neuropathol 130(6):751\u201364.\u00a0https:\/\/doi.org\/10.1007\/s00401-015-1471-7","DOI":"10.1007\/s00401-015-1471-7"},{"issue":"1","key":"1114_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13365-012-0080-7","volume":"18","author":"A Bellizzi","year":"2012","unstructured":"Bellizzi A, Nardis C, Anzivino E, Rod\u00eco D, Fioriti D, Mischitelli M, Chiarini F, Pietropaolo V (2012) Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies. J Neurovirol 18(1):1\u201311. https:\/\/doi.org\/10.1007\/s13365-012-0080-7","journal-title":"J Neurovirol"},{"issue":"15","key":"1114_CR4","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB, Davis L, Koralnik IJ, Sejvar JJ, Bartt R, Major EO, Nath A (2013) PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 80(15):1430\u20131438. https:\/\/doi.org\/10.1212\/WNL.0b013e31828c2fa1","journal-title":"Neurology"},{"issue":"5","key":"1114_CR5","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1128\/AAC.01614-08","volume":"53","author":"M Brickelmaier","year":"2009","unstructured":"Brickelmaier M, Lugovskoy A, Kartikeyan R, Reviriego-Mendoza MM, Allaire N, Simon K, Frisque RJ, Gorelik L (2009) Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53(5):1840\u20131849. https:\/\/doi.org\/10.1128\/AAC.01614-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1114_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s13365-013-0173-y","volume":"19","author":"DB Clifford","year":"2013","unstructured":"Clifford DB, Nath A, Cinque P, Brew BJ, Zivadinov R, Gorelik L, Zhao Z, Duda P (2013) A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes. J Neurovirol 19(4):351\u2013358. https:\/\/doi.org\/10.1007\/s13365-013-0173-y","journal-title":"J Neurovirol"},{"issue":"1","key":"1114_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","volume":"17","author":"I Cortese","year":"2021","unstructured":"Cortese I, Reich DS, Nath A (2021) Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol 17(1):37\u201351. https:\/\/doi.org\/10.1038\/s41582-020-00427-y","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1114_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1086\/595299","volume":"199","author":"FN Engsig","year":"2009","unstructured":"Engsig FN, Hansen AB, Omland LH, Kronborg G, Gerstoft J, Laursen AL, Pedersen C, Mogensen CB, Nielsen L, Obel N (2009) Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis 199(1):77\u201383. https:\/\/doi.org\/10.1086\/595299","journal-title":"J Infect Dis"},{"key":"1114_CR9","doi-asserted-by":"publisher","unstructured":"Graf LM, Rosenkranz SC, H\u00f6lzemer A, Hagel C, Goebell E, Jordan S, Friese MA, Addo MM, Schulze Zur Wiesch J, Beisel C (2021) Clinical presentation and disease course of 37 consecutive cases of progressive multifocal leukoencephalopathy (PML) at a German tertiary-care hospital: a retrospective observational study. Front Neurol 12:632535.\u00a0https:\/\/doi.org\/10.3389\/fneur.2021.632535","DOI":"10.3389\/fneur.2021.632535"},{"issue":"3","key":"1114_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00415-019-09629-x","volume":"267","author":"M Hamaguchi","year":"2020","unstructured":"Hamaguchi M, Suzuki K, Fujita H, Uzuka T, Matsuda H, Shishido-Hara Y, Arai S, Nakamura T, Kikuchi S, Nakamichi K, Saijo M, Hirata K (2020) Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review. J Neurol 267(3):731\u2013738. https:\/\/doi.org\/10.1007\/s00415-019-09629-x","journal-title":"J Neurol"},{"key":"1114_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/DNND.S203405","volume":"9","author":"M Kartau","year":"2019","unstructured":"Kartau M, Sipil\u00e4 JO, Auvinen E, Palom\u00e4ki M, Verkkoniemi-Ahola A (2019) Progressive multifocal leukoencephalopathy: current insights. Degener Neurol Neuromuscul Dis 9:109\u2013121. https:\/\/doi.org\/10.2147\/DNND.S203405","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"23","key":"1114_CR12","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJM198212023072307","volume":"307","author":"JR Miller","year":"1982","unstructured":"Miller JR, Barrett RE, Britton CB, Tapper ML, Bahr GS, Bruno PJ, Marquardt MD, Hays AP, McMurtry JG 3rd, Weissman JB, Bruno MS (1982) Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. N Engl J Med 307(23):1436\u20131438. https:\/\/doi.org\/10.1056\/NEJM198212023072307","journal-title":"N Engl J Med"},{"issue":"6","key":"1114_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.2146\/ajhp110392","volume":"69","author":"RP Moenster","year":"2012","unstructured":"Moenster RP, Jett RA (2012) Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus. Am J Health Syst Pharm 69(6):496\u2013498. https:\/\/doi.org\/10.2146\/ajhp110392","journal-title":"Am J Health Syst Pharm"},{"issue":"1\u20132","key":"1114_CR14","first-page":"33","volume":"15","author":"C Mullins","year":"2018","unstructured":"Mullins C, Miranda J, Sandoval H, Ramos-Duran L, Tonarelli SB (2018) The benefit of mirtazapine in the treatment of progressive multifocal leukoencephalopathy in a young HIV-positive patient: a case report. Innov Clin Neurosci 15(1\u20132):33\u201335","journal-title":"Innov Clin Neurosci"},{"issue":"5","key":"1114_CR15","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.4103\/neuroindia.NI_535_16","volume":"65","author":"A Nambirajan","year":"2017","unstructured":"Nambirajan A, Suri V, Kataria V, Sharma MC, Goyal V (2017) Progressive multifocal leukoencephalopathy in a 44-year old male with idiopathic CD4+ T-lymphocytopenia treated with mirtazapine and mefloquine. Neurol India 65(5):1061\u20131064. https:\/\/doi.org\/10.4103\/neuroindia.NI_535_16","journal-title":"Neurol India"},{"issue":"5","key":"1114_CR16","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/rheumatology\/kem049","volume":"46","author":"K Owczarczyk","year":"2007","unstructured":"Owczarczyk K, Hilker R, Brunn A, Hallek M, Rubbert A (2007) Progressive multifocal leucoencephalopathy in a patient with sarcoidosis\u2013successful treatment with cidofovir and mirtazapine. Rheumatology (oxford) 46(5):888\u2013890. https:\/\/doi.org\/10.1093\/rheumatology\/kem049","journal-title":"Rheumatology (oxford)"},{"issue":"1","key":"1114_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s13365-016-0465-0","volume":"23","author":"DN Soleimani-Meigooni","year":"2017","unstructured":"Soleimani-Meigooni DN, Schwetye KE, Angeles MR, Ryschkewitsch CF, Major EO, Dang X, Koralnik IJ, Schmidt RE, Clifford DB, Kuhlmann FM, Bucelli RC (2017) JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7. J Neurovirol 23(1):141\u2013146. https:\/\/doi.org\/10.1007\/s13365-016-0465-0","journal-title":"J Neurovirol"},{"issue":"9","key":"1114_CR18","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/jnnp.2006.092353","volume":"77","author":"S Vulliemoz","year":"2006","unstructured":"Vulliemoz S, Lurati-Ruiz F, Borruat FX, Delavelle J, Koralnik IJ, Kuntzer T, Bogousslavsky J, Picard F, Landis T, Du Pasquier RA (2006) Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry 77(9):1079\u20131082. https:\/\/doi.org\/10.1136\/jnnp.2006.092353","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-023-01114-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-023-01114-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-023-01114-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T14:56:29Z","timestamp":1681224989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-023-01114-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1114"],"URL":"https:\/\/doi.org\/10.1007\/s13365-023-01114-6","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"9 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics committee approval was needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}